Temporal lobe microstructural abnormalities in patients with nasopharyngeal carcinoma quantitatively evaluated by high-resolution DWI and DKI after concurrent chemoradiotherapy

Temporal lobe microstructural abnormalities in patients with nasopharyngeal carcinoma quantitatively evaluated by high-resolution DWI and DKI after concurrent chemoradiotherapy

Purpose: To investigate temporal lobe microstructural abnormalities and neurocognitive function impairment after concurrent chemoradiotherapy (CCRT) in patients with nasopharyngeal carcinoma (NPC). Methods: NPC patients who underwent CCRT were enrolled. High-resolution diffusion-weighted imaging (DW...

Full description

Bibliographic Details
Main Authors:	Gang Wu, Rui-rui Li, Priya S. Balasubramanian, Meng-meng Li, Kai Yang, Wei-yuan Huang, Feng Chen
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	Clinical and Translational Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630819301168

Similar Items

In Vivo Imaging Markers for Prediction of Radiotherapy Response in Patients with Nasopharyngeal Carcinoma: RESOLVE DWI versus DKI
by: Wei-Yuan Huang, et al.
Published: (2018-10-01)

Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma
by: Changmin Liu, et al.
Published: (2020-01-01)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
by: Guoqiang Xu MD, et al.
Published: (2021-01-01)

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
by: Li Z, et al.
Published: (2017-11-01)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
by: Jiraporn Setakornnukul, et al.
Published: (2018-03-01)

Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients
by: Thongyai Kanthong, et al.
Published: (2011-02-01)

Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2021-03-01)

The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma
by: Liang ZG, et al.
Published: (2020-02-01)

Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.
by: Li Yin, et al.
Published: (2015-01-01)

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Kailin Wang, et al.
Published: (2019-05-01)

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Rui Zou, et al.
Published: (2021-02-01)

The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis
by: Bi-Cheng Wang, et al.
Published: (2020-05-01)

The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapy.
by: Shiping Yang, et al.
Published: (2015-01-01)

Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update
by: Ting Jin, et al.
Published: (2020-01-01)

Induction chemotherapy followed by radiotherapy concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2020-06-01)

Central pontine myelinolysis (CPM) and extrapontine myelinolysis (EPM) following concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Chen-Hui Chong, et al.
Published: (2016-06-01)

New Onset Diplopia in Patients with Nasopharyngeal Carcinoma following Concurrent Chemoradiotherapy: Clinical Features and Etiology
by: Hui-Chuan Kau, et al.
Published: (2015-01-01)

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study
by: Yang Li, et al.
Published: (2017-08-01)

Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?
by: Ji-Jin Yao, et al.
Published: (2019-03-01)

Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2020-01-01)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
by: Zhen Zeng, et al.
Published: (2018-10-01)

Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis
by: Ji-Jin Yao, et al.
Published: (2017-03-01)

The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N3 disease
by: Yingying Zhang, et al.
Published: (2017-06-01)

Preliminary research of the classification of the brain acute stroke lesions by the Diffusion Kurtosis Imaging (DKI) and Diffusion Weighted Imaging (DWI) parameters
by: Chen, F., et al.
Published: (2023)

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study
by: Qiuyan Chen, et al.
Published: (2018-11-01)

Longitudinal Trend of Health-Related Quality of Life During Concurrent Chemoradiotherapy and Survival in Patients With Stage II–IVb Nasopharyngeal Carcinoma
by: Ji-Bin Li, et al.
Published: (2020-10-01)

Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
by: Cui-Dai Zhang, et al.
Published: (2021-06-01)

Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy
by: Seung Hwan Moon, et al.
Published: (2015-06-01)

Study of plasma matrix metalloproteinase -2 and -9 level during concurrent chemoradiotherapy and clinicopathologic significance in patients with nasopharyngeal carcinoma
by: Chien-Yi, et al.
Published: (2009)

Bronchopleural Fistula After Concurrent Chemoradiotherapy
by: Jorien M. van de Pas, MD, et al.
Published: (2020-05-01)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)

Investigation on the Efficiency of Chinese Herbal Injections combined with Concurrent Chemoradiotherapy for Treating Nasopharyngeal Carcinoma based on Multidimensional Bayesian Network Meta-analysis
by: Zhishan Wu, et al.
Published: (2021-06-01)

Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
by: Jun-Fang Liao, et al.
Published: (2019-06-01)

Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand
by: Nuttapong Ngamphaiboon, et al.
Published: (2020-06-01)

Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study
by: Xia WX, et al.
Published: (2019-11-01)

The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis
by: Ji-Jin Yao, et al.
Published: (2018-07-01)

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
by: He Y, et al.
Published: (2018-06-01)

Pretreatment Plasma EBV-DNA Load Guides Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer: A Meta-Analysis
by: Lin Lai, et al.
Published: (2021-02-01)

The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase iii randomized trials
by: Guo Ying, et al.
Published: (2010-10-01)

Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
by: Erraki Abdelouahed, et al.
Published: (2009-04-01)